(Q44390794)

2 December 2017

title

5-Fluorouracil and cisplatin in the treatment of advanced oral cancer (English)

1 reference

lip and oral cavity carcinoma

2 December 2017

1 reference

1 reference

1 reference

Andreadis C

1

1 reference

2 December 2017

Vahtsevanos K

2

1 reference

2 December 2017

Sidiras T

3

1 reference

2 December 2017

Thomaidis I

4

1 reference

2 December 2017

Antoniadis K

5

1 reference

2 December 2017

Mouratidou D

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

39

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

380-385

1 reference

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Chemotherapy of squamous cell carcinoma of head and neck: the future is now.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

A phase III randomised trial of cistplatinum, methotrextate, cisplatinum + methotrexate and cisplatinum + 5-FU in end stage squamous carcinoma of the head and neck. Liverpool Head and Neck Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Overview of combined modality therapies for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Prognostic indicators in head and neck cancer patients receiving combined therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Intensive chemotherapy using cisplatin and fluorouracil followed by radiotherapy in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Analysis of complete responders after initial treatment with chemotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Carboplatin plus ftorafur as a palliative treatment in locally advanced cancer of the oral cavity and lip.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

High rate of clinical complete response to weekly outpatient neoadjuvant chemotherapy in oral carcinoma patients using a new regimen of cisplatin, 5-fluorouracil, and bleomycin alternating with methotrexate and epirubicin

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2802%2900141-0

7 January 2021

10.1016/S1368-8375(02)00141-0

Identifiers

DOI

1 reference

2 December 2017

1 reference